According to their results, 38% of patients were prescribed at least one GO-PIMs, most-commonly selective serotonin reuptake inhibitors (SSRIs). Each additional GO-PIM was associated with a 66% ...

The details on the registration page are quite broad and they don’t show the duration of the event, nor a specific schedule of when individual topics will be covered. Even so, it may be worth ...

These 2025 Damon Runyon cancer research fellows study bone-deep pain, bacterial secretions, re-engineered viruses, gamma delta T cells and more.

Every year the second Saturday of October marks World Hospice and Palliative Care Day (WHPCD). This year WHPCD will be on Saturday 11 October 2025. Each year the WHPCD campaign has a theme that is ...

SARS-CoV-2, the virus that causes COVID-19, and other respiratory infections can awaken latent breast cancer cells that have spread to the lungs, potentially raising the risk for relapse, according to ...

Features How Do you Measure Health? BMI Isn’t Enough, Finds Data from Women’s Health Initiative New studies using Women’s Health Initiative data highlight new “biomarkers” to predict mortality risk ...

Radiation therapy has been proposed as one possible way to induce a systemic immune response because of a unique phenomenon called the abscopal effect. Radiation at the site of a primary tumor ...

Laura Beilke Glendale, Wisconsin As a youngster, Laura Beilke lost her mother to cancer. This experience fueled her decision to become a patient advocate. Today, she’s a staff attorney at Triage ...

“The latest data from the Phase I trial are encouraging,” lead investigator Vinod Balachandran, MD, of Memorial Sloan Kettering Cancer Center, said in a news release. “They suggest this ...

“It’s simply unacceptable to continue to allow cancer-causing chemicals to be used for things like glue, dry cleaning or stain removers when safer alternatives exist,” said Michal Freedhoff, assistant ...

Due to advances in prevention, early detection and treatment, the age-adjusted overall cancer death rate in the U.S. fell by 33% between 1991 and 2021.

Incyte’s PD-1 checkpoint inhibitor Zynyz (retifanlimab) plus chemotherapy significantly improved progression-free survival in previously untreated patients with advanced anal cancer, according to late ...